Rosemary A. Underhill
Rosemary A. Underhill has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
John Dewhurst
Institute of Obstetrics and Gynaecology, Queen Charlotte's Maternity Hospital, Goldhawk Road, London W.6., U.K
2 shared publicationsJohn M. Beazley
2 shared publicationsStuart Campbell
2 shared publicationsAlan Gurwitt
Yale Child Study Center, Harvard Medical School, University of Connecticut School of Medicine, Newton Highlands, MA, United States
1 shared publicationC. J. Dewhurst
Institute of Obstetrics and Gynaecology, Chelsea Hospital for Women Dovehouse Street, London SW3
1 shared publicationI. Craft
1 shared publication
Latest Publications
- Open Access
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Organic Disease or Psychosomatic Illness? A Re-Examination of the Royal Free Epidemic of 1955
Background and Objectives: Controversy exists over whether myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an organic disease or a psychosomatic illness. ME/CFS usually occurs as sporadic cases, but epidemics (outbreaks) have occurred worldwide. Myalgic encephalomyelitis was named to describe an outbreak affecting the lymphatic, muscular, and nervous systems that closed the Royal Free hospital for three months in 1955. Fifteen years later, two psychiatrists concluded that epidemic hysteria was the likely cause. ME/CFS research studies show multiple pathophysiological differences between patients and controls and a possible etiological role for infectious organisms, but the belief that ME/CFS is psychosomatic is widespread and has been specifically supported by the epidemic hysteria hypothesis for the Royal Free outbreak. Our objective was to obtain accounts from ex-Royal Free hospital staff who personally experienced the 1955 outbreak and evaluate evidence for it being an infectious illness versus epidemic hysteria. Materials and Methods: Statements in the newsletters of two organizations for staff who had worked at the Royal Free hospital invited anyone who had experienced the 1955 Royal Free outbreak to contact the authors. Accounts of the outbreak from telephone interviews and letters were evaluated against the “epidemic hysteria hypothesis” paper and original medical staff reports. Results: Twenty-seven ex-Royal Free hospital staff, including six who had developed ME, provided descriptions typical of an infectious illness affecting the lymphatic, muscular, and nervous systems, and were not consistent with epidemic hysteria. Conclusions: The 1955 Royal Free hospital epidemic of myalgic encephalomyelitis was an organic infectious disease, not psychogenic epidemic hysteria.
Open AccessMyalgic Encephalomyelitis/Chronic Fatigue Syndrome: Organic Disease or Psychosomatic Illness? A Re-Examination of the Royal Free Epidemic of 1955
Background and Objectives: Controversy exists over whether myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an organic disease or a psychosomatic illness. ME/CFS usually occurs as sporadic cases, but epidemics (outbreaks) have occurred worldwide. Myalgic encephalomyelitis was named to describe an outbreak affecting the lymphatic, muscular, and nervous systems that closed the Royal Free hospital for three months in 1955. Fifteen years later, two psychiatrists concluded that epidemic hysteria was the likely cause. ME/CFS research studies show multiple pathophysiological differences between patients and controls and a possible etiological role for infectious organisms, but the belief that ME/CFS is psychosomatic is widespread and has been specifically supported by the epidemic hysteria hypothesis for the Royal Free outbreak. Our objective was to obtain accounts from ex-Royal Free hospital staff who personally experienced the 1955 outbreak and evaluate evidence for it being an infectious illness versus epidemic hysteria. Materials and Methods: Statements in the newsletters of two organizations for staff who had worked at the Royal Free hospital invited anyone who had experienced the 1955 Royal Free outbreak to contact the authors. Accounts of the outbreak from telephone interviews and letters were evaluated against the “epidemic hysteria hypothesis” paper and original medical staff reports. Results: Twenty-seven ex-Royal Free hospital staff, including six who had developed ME, provided descriptions typical of an infectious illness affecting the lymphatic, muscular, and nervous systems, and were not consistent with epidemic hysteria. Conclusions: The 1955 Royal Free hospital epidemic of myalgic encephalomyelitis was an organic infectious disease, not psychogenic epidemic hysteria.
- Open Access
- 19 June 2017
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 5, 121
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease that affects children and adolescents as well as adults. The etiology has not been established. While many pediatricians and other healthcare providers are aware of ME/CFS, they often lack essential knowledge that is necessary for diagnosis and treatment. Many young patients experience symptoms for years before receiving a diagnosis. This Primer, written by the International Writing Group for Pediatric ME/CFS provides information necessary to understand, diagnose, and man-age the symptoms of ME/CFS in children and adolescents. ME/CFS is characterized by overwhelming fatigue with a substantial loss of physical and mental stamina. Cardinal features are malaise and a worsening of symptoms following minimal physical or mental exertion. These post-exertional symptoms can persist for hours, days, or weeks and are not relieved by rest or sleep. Other symptoms include cognitive problems, unrefreshing or disturbed sleep, generalized or localized pain, light-headedness and additional symptoms in multiple organ systems. While some young patients can attend school, on a full or part-time basis, many others are wheelchair dependent, housebound, or bedbound. Prevalence estimates for pediatric ME/CFS vary from 0.1%-0.5%. Because there is no diagnostic test for ME/CFS, diagnosis is purely clinical, based on the history and the exclusion of other fatiguing illnesses by physical examination and medical testing. Co-existing medical conditions including orthostatic intolerance are common. Successful management is based on determining the optimum balance of rest and activity to help prevent post-exertional symptom worsening. Medications are helpful to treat pain, insomnia, orthostatic intolerance and other symptoms. The published literature on ME/CFS and specifically that describing the diagnosis and management of pediatric ME/CFS is very limited. Where published studies are lacking, recommendations are based on the clinical observations and practices of the authors.
- 19 June 2017
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 5, 121
Open AccessMyalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease that affects children and adolescents as well as adults. The etiology has not been established. While many pediatricians and other healthcare providers are aware of ME/CFS, they often lack essential knowledge that is necessary for diagnosis and treatment. Many young patients experience symptoms for years before receiving a diagnosis. This Primer, written by the International Writing Group for Pediatric ME/CFS provides information necessary to understand, diagnose, and man-age the symptoms of ME/CFS in children and adolescents. ME/CFS is characterized by overwhelming fatigue with a substantial loss of physical and mental stamina. Cardinal features are malaise and a worsening of symptoms following minimal physical or mental exertion. These post-exertional symptoms can persist for hours, days, or weeks and are not relieved by rest or sleep. Other symptoms include cognitive problems, unrefreshing or disturbed sleep, generalized or localized pain, light-headedness and additional symptoms in multiple organ systems. While some young patients can attend school, on a full or part-time basis, many others are wheelchair dependent, housebound, or bedbound. Prevalence estimates for pediatric ME/CFS vary from 0.1%-0.5%. Because there is no diagnostic test for ME/CFS, diagnosis is purely clinical, based on the history and the exclusion of other fatiguing illnesses by physical examination and medical testing. Co-existing medical conditions including orthostatic intolerance are common. Successful management is based on determining the optimum balance of rest and activity to help prevent post-exertional symptom worsening. Medications are helpful to treat pain, insomnia, orthostatic intolerance and other symptoms. The published literature on ME/CFS and specifically that describing the diagnosis and management of pediatric ME/CFS is very limited. Where published studies are lacking, recommendations are based on the clinical observations and practices of the authors.
- Open Access
- 1 December 2015
- Published by Elsevier in Medical Hypotheses
- Vol. 85 (6) , 765-773
Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease
- 1 December 2015
- Published by Elsevier in Medical Hypotheses
- Vol. 85 (6) , 765-773
Open AccessMyalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease
- 1 January 2006
- Published by Taylor & Francis in Journal of Chronic Fatigue Syndrome
- Vol. 13 (1) , 3-13
Prevalence of Chronic Fatigue Syndrome and Chronic Fatigue Within Families of CFS Patients
- 1 January 2006
- Published by Taylor & Francis in Journal of Chronic Fatigue Syndrome
- Vol. 13 (1) , 3-13
Prevalence of Chronic Fatigue Syndrome and Chronic Fatigue Within Families of CFS Patients
- 1 February 1979
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 86 (2) , 139-141
FURTHER CLINICAL EXPERIENCEIN THE TREATMENT OF HIRSUTISM WITH CYPROTERONE ACETATE
Further experience in the treatment of female hirsutism with the anti-androgen cyproterone acetate is reported. Two-thirds of treated patients have shown improvement but relapse occurred within two or three months of stopping treatment. Acne also healed in two patients.
- 1 February 1979
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 86 (2) , 139-141
FURTHER CLINICAL EXPERIENCEIN THE TREATMENT OF HIRSUTISM WITH CYPROTERONE ACETATE
Further experience in the treatment of female hirsutism with the anti-androgen cyproterone acetate is reported. Two-thirds of treated patients have shown improvement but relapse occurred within two or three months of stopping treatment. Acne also healed in two patients.
- 1 February 1978
- Published by Elsevier in The Lancet
- Vol. 311 (8060) , 375-376
THE DOCTOR CANNOT ALWAYS TELL
- 1 February 1978
- Published by Elsevier in The Lancet
- Vol. 311 (8060) , 375-376
THE DOCTOR CANNOT ALWAYS TELL
- 1 February 1977
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 84 (2) , 119-123
THE TREATMENT OF HIRSUTISM WITH CYPROTERONE ACETATE (AN ANTI‐ANDROGEN)
Summary: The rationale of anti‐androgen treatment for hirsutism is explained. The results are presented of treatment with cyproterone acetate of idiopathic hirsutism or hirsutism associated with polycystic ovarian disease. Ten out of 14 patients showed a good response after six months treatment. The response was dramatic in two patients.
- 1 February 1977
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 84 (2) , 119-123
THE TREATMENT OF HIRSUTISM WITH CYPROTERONE ACETATE (AN ANTI‐ANDROGEN)
Summary: The rationale of anti‐androgen treatment for hirsutism is explained. The results are presented of treatment with cyproterone acetate of idiopathic hirsutism or hirsutism associated with polycystic ovarian disease. Ten out of 14 patients showed a good response after six months treatment. The response was dramatic in two patients.
- 1 November 1974
- Vol. 10 (11) , 346-50
Diagnosis of placenta praevia by ultrasound.
- 1 April 1974
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 28 (4) , 134-136
Causes of Therapeutic Failure after Treatment of Trichomonal Vaginitis with Metronidazole: Comparison of Single‐dose Treatment with a Standard Regimen
- 1 April 1974
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 28 (4) , 134-136
Causes of Therapeutic Failure after Treatment of Trichomonal Vaginitis with Metronidazole: Comparison of Single‐dose Treatment with a Standard Regimen